Guest
Guest
May 17, 2026
11:11 PM
|
Moreover, we are capable of customizing artificial T cell stimulation platforms to meet specific therapeutic needs, such as targeting specific T cell subsets or delivering particular payloads alongside the activation signal. To evaluate the safety and efficacy of the platforms, we will conduct thorough preclinical studies that include in vivo studies and in vitro studies. Based on our robust platforms, we are confident in our ability to deliver high-performing artificial T cell-stimulators within our customers' expected timeframes.
|
